Literature DB >> 3971540

Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy.

K Kohchi, S Takebayashi, T Hiroki, M Nobuyoshi.   

Abstract

A quantitative analysis of adventitial inflammation of the coronary artery with intimal lesions is described in 12 patients who suffered coronary death and had had unstable angina (crescendo angina) at rest (group 1). After autopsy in these patients we examined epon-embedded cross sections by light and electron microscopy, paying particular attention to the adventitia, and compared these results with those in six patients who had had angina but died of noncardiac causes (group 2) and those in 22 patients who did not have angina (group 3). Of the 132 segments from group 1 patients, 39 (30%) were narrowed 76% to 100% by atherosclerotic plaque (group 2, 27%; group 3, 1%), and 23 (17%) had occlusive thrombi. Of the 264 sections (two from each segment) from group 1 that were examined, 98 (37%) (group 2, 15%; group 3, 9%) revealed clustered infiltration of inflammatory cells in the adventitia, half of which were associated with vascular nerve involvement. These findings in the adventitia may be related to the vasospastic component of unstable angina.

Entities:  

Mesh:

Year:  1985        PMID: 3971540     DOI: 10.1161/01.cir.71.4.709

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina.

Authors:  G V Moukarbel; M S Arnaout; S E Alam
Journal:  Clin Cardiol       Date:  2001-07       Impact factor: 2.882

2.  Inflammation of the coronary arteries in patients with unstable angina.

Authors:  E Wallsh; G S Weinstein; A Franzone; A Clavel; P A Rossi; E Kreps
Journal:  Tex Heart Inst J       Date:  1986-03

3.  Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling.

Authors:  Brian C Tieu; Xiaoxi Ju; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Allan R Brasier; Ronald G Tilton
Journal:  J Vasc Res       Date:  2010-11-23       Impact factor: 1.934

4.  Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.

Authors:  Min Li; Suzette R Riddle; Maria G Frid; Karim C El Kasmi; Timothy A McKinsey; Ronald J Sokol; Derek Strassheim; Barbara Meyrick; Michael E Yeager; Amanda R Flockton; B Alexandre McKeon; Douglas D Lemon; Todd R Horn; Adil Anwar; Carlos Barajas; Kurt R Stenmark
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

5.  Successful treatment using corticosteroids in a patient with refractory vasospastic angina and bronchial asthma.

Authors:  Yohei Numasawa; Hiroyuki Motoda; Hiroyuki Yamazaki; Toshiki Kuno; Kuniyuki Urushibara; Toshiyuki Takahashi
Journal:  J Cardiol Cases       Date:  2014-08-07

Review 6.  Inflammation in acute coronary syndromes.

Authors:  N T Mulvihill; J B Foley
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

7.  Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

Authors:  D Hasdai; M Scheinowitz; E Leibovitz; S Sclarovsky; M Eldar; V Barak
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

8.  In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes.

Authors:  Hyunggun Kim; Melanie R Moody; Susan T Laing; Patrick H Kee; Shao-Ling Huang; Melvin E Klegerman; David D McPherson
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

Review 9.  Coronary Vasospastic Angina: Current Understanding and the Role of Inflammation.

Authors:  Ming-Jui Hung; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

10.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Authors:  B N Cronstein; R I Levin; J Belanoff; G Weissmann; R Hirschhorn
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.